Part I: Foundations of Metabolism
Thermodynamics, Enzymes, and the Logic of Metabolic Pathways
Overview
Before we trace carbon atoms through glycolysis or follow electrons down the respiratory chain, we must build a rigorous foundation in the physical and chemical principles that govern every metabolic transformation. This part addresses three fundamental questions: Why do metabolic reactions occur? How fast do they proceed? And how does the cell control their rates?
We begin with thermodynamics — the science of energy transformations — and learn how Gibbs free energy dictates the spontaneity and direction of biochemical reactions. We then explore enzyme kinetics, developing the mathematical framework of Michaelis-Menten theory from first principles. From there we examine the sophisticated mechanisms cells use to regulate enzyme activity, survey the essential coenzymes and cofactors that participate in metabolic chemistry, and finally identify the recurring logical patterns that connect individual reactions into coherent pathways.
Mastery of these foundations is essential. Every pathway we encounter in subsequent parts — from glycolysis to fatty acid oxidation to the urea cycle — operates under these same thermodynamic constraints, obeys these same kinetic laws, and is governed by these same regulatory principles.
Chapter 1: Thermodynamics of Life
Living organisms are thermodynamic systems. They are not exempt from the laws of physics — rather, they are exquisitely adapted to operate within those laws. Understanding metabolism requires understanding the thermodynamic principles that dictate which reactions can occur spontaneously, how much useful work can be extracted from a chemical transformation, and why organisms must continuously consume energy to maintain their organized state.
1.1 The First Law: Conservation of Energy
The first law of thermodynamics states that energy can be neither created nor destroyed, only converted from one form to another. For a biological system, this means that all the chemical energy stored in the bonds of nutrients must be accounted for — it is either converted to useful work (muscle contraction, active transport, biosynthesis), released as heat, or stored in the bonds of new molecules.
Mathematically, for a system at constant pressure (which describes most biological processes), the first law is expressed through the enthalpy change:
\[\Delta H = q_p\]
where \(\Delta H\) is the enthalpy change and \(q_p\) is the heat exchanged at constant pressure.
When \(\Delta H < 0\), the reaction is exothermic — it releases heat to the surroundings. The combustion of glucose, for instance, has \(\Delta H = -2803 \text{ kJ/mol}\), meaning each mole of glucose burned releases 2803 kJ of heat energy. When \(\Delta H > 0\), the reaction is endothermic and absorbs heat.
1.2 The Second Law: Entropy Always Increases
The second law states that in any spontaneous process, the total entropy of the universe increases. Entropy (\(S\)) is a measure of the dispersal of energy and the randomness or disorder of a system. A process is spontaneous if:
\[\Delta S_{\text{universe}} = \Delta S_{\text{system}} + \Delta S_{\text{surroundings}} > 0\]
This is a profound statement for biology. Living organisms are highly ordered — they maintain low internal entropy. At first glance, this seems to violate the second law. However, organisms are open systems that continuously exchange matter and energy with their surroundings. They decrease their own entropy at the expense of increasing the entropy of the surroundings by an even greater amount, typically by releasing heat and producing small, disordered waste molecules (CO\(_2\), H\(_2\)O, urea).
Key Concept: Organisms as Open Systems
A living cell is an open thermodynamic system — it exchanges both energy and matter with its environment. It maintains a low-entropy, far-from-equilibrium state by continuously importing high-energy, low-entropy nutrients (glucose, fatty acids) and exporting low-energy, high-entropy waste products (CO\(_2\), H\(_2\)O). If this flow of energy and matter ceases, the system reaches equilibrium — which, for a living organism, means death.
1.3 Gibbs Free Energy: The Criterion for Spontaneity
Tracking the entropy of the entire universe for every biochemical reaction is impractical. J. Willard Gibbs solved this problem by defining a new thermodynamic quantity — the Gibbs free energy, \(G\) — that allows us to predict spontaneity by examining the system alone:
\[G = H - TS\]
For a process at constant temperature and pressure, the change in Gibbs free energy is:
\[\Delta G = \Delta H - T\Delta S\]
Mathematical Deep Dive: Deriving the Free Energy Criterion
From the second law, a process is spontaneous when \(\Delta S_{\text{universe}} > 0\). At constant temperature and pressure:
\[\Delta S_{\text{surroundings}} = -\frac{\Delta H_{\text{system}}}{T}\]
Substituting into the second law expression:
\[\Delta S_{\text{system}} + \left(-\frac{\Delta H_{\text{system}}}{T}\right) > 0\]
Multiplying both sides by \(-T\) (and flipping the inequality):
\[\Delta H_{\text{system}} - T\Delta S_{\text{system}} < 0\]
This is precisely \(\Delta G < 0\). Thus, a reaction is spontaneous (exergonic) when\(\Delta G < 0\), at equilibrium when \(\Delta G = 0\), and non-spontaneous (endergonic) when \(\Delta G > 0\).
1.4 Enthalpy vs Entropy: Competing Driving Forces
The equation \(\Delta G = \Delta H - T\Delta S\) reveals that spontaneity depends on the interplay of two factors: the enthalpy change (a measure of bond energy changes) and the entropy change (a measure of disorder change), weighted by temperature.
| \(\Delta H\) | \(\Delta S\) | \(\Delta G\) | Spontaneity |
|---|---|---|---|
| \(< 0\) (exothermic) | \(> 0\) (disorder increases) | Always \(< 0\) | Spontaneous at all T |
| \(> 0\) (endothermic) | \(< 0\) (disorder decreases) | Always \(> 0\) | Never spontaneous |
| \(< 0\) | \(< 0\) | Depends on T | Spontaneous at low T |
| \(> 0\) | \(> 0\) | Depends on T | Spontaneous at high T |
1.5 Life Far from Equilibrium
At thermodynamic equilibrium, \(\Delta G = 0\) and no net work can be extracted. A living cell at equilibrium is a dead cell. Life exists in a steady state far from equilibrium, where concentrations of metabolites are maintained at levels that keep \(\Delta G\) significantly negative for essential reactions. This requires a continuous input of free energy, ultimately derived from sunlight (phototrophs) or from the oxidation of reduced inorganic or organic compounds (chemotrophs).
The magnitude of \(\Delta G\) determines the maximum useful work available from a reaction. Cells have evolved to capture a remarkably large fraction of this available free energy, typically 40-60%, compared to \(\sim\)25-35% for most human-engineered heat engines.
Clinical Relevance: Metabolic Rate and Calorimetry
The basal metabolic rate (BMR) is the rate of energy expenditure at rest — approximately 1500-1800 kcal/day for an average adult. It can be measured by indirect calorimetry, which uses oxygen consumption (\(\dot{V}O_2\)) and CO\(_2\) production (\(\dot{V}CO_2\)) to calculate heat production. The respiratory quotient \(RQ = \dot{V}CO_2 / \dot{V}O_2\) reveals which fuel substrates are being oxidized: \(RQ = 1.0\) for pure carbohydrate oxidation,\(RQ \approx 0.7\) for fat, and \(RQ \approx 0.8\) for protein. In clinical settings, indirect calorimetry guides nutritional support for critically ill patients.
Chapter 2: Free Energy & Coupled Reactions
While Chapter 1 established the thermodynamic framework, we now apply it quantitatively to biochemical reactions. We introduce the biochemical standard free energy change, learn to calculate actual free energies under cellular conditions, and discover how cells use reaction coupling to drive thermodynamically unfavorable but biologically essential reactions.
2.1 Standard Free Energy Change: \(\Delta G^{\circ\prime}\)
Biochemists define a biochemical standard state that differs from the chemical standard state in two important ways: the pH is fixed at 7.0 (so \([H^+] = 10^{-7}\) M rather than 1 M), and the activity of water is taken as 1 (since water is the solvent at 55.5 M). All other solutes are at 1 M concentration, temperature is 298 K (25 \(^\circ\)C), and pressure is 1 atm.
The biochemical standard free energy change, \(\Delta G^{\circ\prime}\), is the free energy change when reactants and products are all at their standard concentrations under these biochemical conditions. The prime symbol (\(^\prime\)) distinguishes it from the chemical standard \(\Delta G^\circ\).
2.2 Free Energy and Equilibrium
The standard free energy change is directly related to the equilibrium constant of the reaction. For a reaction \(A \rightleftharpoons B\):
\[\Delta G^{\circ\prime} = -RT \ln K'_{\text{eq}}\]
where \(R = 8.314 \text{ J mol}^{-1}\text{K}^{-1}\) and \(T = 298 \text{ K}\)
This relationship reveals that a large negative \(\Delta G^{\circ\prime}\) corresponds to a large \(K'_{\text{eq}}\) — the reaction strongly favors products at equilibrium. Conversely, a large positive \(\Delta G^{\circ\prime}\) means \(K'_{\text{eq}} \ll 1\) and reactants are favored.
| \(\Delta G^{\circ\prime}\) (kJ/mol) | \(K'_{\text{eq}}\) | Direction favored |
|---|---|---|
| -17.1 | 1000 | Strongly favors products |
| -5.7 | 10 | Favors products |
| 0 | 1 | Equilibrium (equal) |
| +5.7 | 0.1 | Favors reactants |
| +17.1 | 0.001 | Strongly favors reactants |
2.3 Actual Free Energy Under Cellular Conditions
The standard free energy change tells us about the equilibrium position, but cells do not operate at equilibrium. The actual free energy change under cellular conditions depends on the concentrations of reactants and products:
\[\Delta G = \Delta G^{\circ\prime} + RT \ln Q\]
where \(Q = \frac{[\text{products}]}{[\text{reactants}]}\) is the mass action ratio (reaction quotient)
Mathematical Deep Dive: Why \(\Delta G^{\circ\prime}\) Can Be Misleading
Consider the isomerization of dihydroxyacetone phosphate (DHAP) to glyceraldehyde-3-phosphate (G3P) in glycolysis: \(\Delta G^{\circ\prime} = +7.5\) kJ/mol. This positive value suggests the reaction should not proceed. However, in the cell, G3P is rapidly consumed by the next enzyme, keeping \([\text{G3P}]\) very low. If \([\text{DHAP}] = 2 \times 10^{-4}\) M and\([\text{G3P}] = 3 \times 10^{-6}\) M:
\[Q = \frac{[\text{G3P}]}{[\text{DHAP}]} = \frac{3 \times 10^{-6}}{2 \times 10^{-4}} = 0.015\]
\[\Delta G = 7.5 + (8.314 \times 10^{-3})(298) \ln(0.015) = 7.5 + (-10.4) = -2.9 \text{ kJ/mol}\]
The reaction is actually exergonic (\(\Delta G < 0\)) under cellular conditions! This illustrates why we must always consider actual concentrations, not just standard values.
2.4 ATP: The Universal Energy Currency
Adenosine triphosphate (ATP) serves as the primary energy currency in all living cells. The hydrolysis of ATP to ADP and inorganic phosphate (P\(_i\)) is strongly exergonic:
\[\text{ATP} + \text{H}_2\text{O} \rightarrow \text{ADP} + \text{P}_i \quad \Delta G^{\circ\prime} = -30.5 \text{ kJ/mol}\]
Under typical cellular conditions, the actual \(\Delta G\) for ATP hydrolysis is even more negative, approximately \(-50\) to \(-55\) kJ/mol, because the cell maintains\([\text{ATP}]/[\text{ADP}][\text{P}_i]\) ratios far from equilibrium. This large free energy of hydrolysis arises from several factors:
- Electrostatic repulsion: The four negative charges on ATP are partially relieved upon hydrolysis
- Resonance stabilization: ADP and P\(_i\) have greater resonance stabilization than ATP
- Hydration: ADP and P\(_i\) are better solvated by water than ATP
- Entropy: Two products (ADP + P\(_i\)) from one reactant
2.5 Phosphoryl Group Transfer Potential
ATP is not the most energetic phosphorylated compound — it occupies an intermediate position on the scale of phosphoryl group transfer potentials. This intermediate position is crucial: it allows ATP to act as a carrier, accepting phosphoryl groups from higher-energy compounds and donating them to lower-energy acceptors.
| Compound | \(\Delta G^{\circ\prime}\) of hydrolysis (kJ/mol) |
|---|---|
| Phosphoenolpyruvate (PEP) | -61.9 |
| 1,3-Bisphosphoglycerate | -49.4 |
| Phosphocreatine | -43.1 |
| ATP \(\rightarrow\) ADP + P\(_i\) | -30.5 |
| ATP \(\rightarrow\) AMP + PP\(_i\) | -45.6 |
| Glucose-1-phosphate | -20.9 |
| Glucose-6-phosphate | -13.8 |
| Glycerol-3-phosphate | -9.2 |
2.6 Coupled Reactions
Many biosynthetic reactions are endergonic — they have a positive \(\Delta G^{\circ\prime}\). Cells drive these reactions forward by coupling them to highly exergonic reactions, most commonly ATP hydrolysis. When two reactions are coupled (share a common intermediate), their free energy changes are additive:
(1) Glucose + P\(_i \rightarrow\) Glucose-6-phosphate + H\(_2\)O \(\quad \Delta G^{\circ\prime} = +13.8\) kJ/mol
(2) ATP + H\(_2\)O \(\rightarrow\) ADP + P\(_i\) \(\quad \Delta G^{\circ\prime} = -30.5\) kJ/mol
Sum: Glucose + ATP \(\rightarrow\) Glucose-6-phosphate + ADP \(\quad \Delta G^{\circ\prime} = -16.7\) kJ/mol
The coupled reaction is now strongly exergonic. In practice, the enzyme hexokinase catalyzes both the phosphoryl group transfer and the coupling simultaneously — the phosphate is never released as free P\(_i\) but is transferred directly from ATP to glucose.
Key Concept: The ATP Cycle
The human body contains only about 250 g of ATP at any given moment, yet turns over approximately 65 kg of ATP per day. This means each molecule of ATP is recycled roughly 300 times daily. ATP is synthesized from ADP + P\(_i\) by oxidative phosphorylation (the primary source), substrate-level phosphorylation, and photophosphorylation (in plants). It is consumed by biosynthetic reactions, active transport, muscle contraction, signal transduction, and numerous other energy-requiring processes.
For Graduate Students: Pyrophosphate Hydrolysis
Some biosynthetic reactions require the hydrolysis of ATP to AMP + PP\(_i\) (pyrophosphate), which releases \(\Delta G^{\circ\prime} = -45.6\) kJ/mol. The subsequent hydrolysis of PP\(_i\) by inorganic pyrophosphatase (\(\Delta G^{\circ\prime} = -19.2\) kJ/mol) makes the overall process effectively irreversible, with a total \(\Delta G^{\circ\prime} = -64.8\) kJ/mol. This strategy is used for reactions that must be driven strongly to completion, such as DNA/RNA synthesis, fatty acid activation, and amino acid activation for translation.
Chapter 3: Enzyme Kinetics
Enzymes are biological catalysts that accelerate reactions by factors of \(10^6\) to\(10^{17}\) without altering the equilibrium position. They achieve this by lowering the activation energy \(\Delta G^\ddagger\) — the energy barrier between reactants and the transition state. Enzyme kinetics provides the quantitative framework for understanding how fast enzymes work, how they respond to substrate concentration, and how their activity can be measured and compared.
3.1 The Enzyme-Substrate Complex
In 1913, Leonor Michaelis and Maud Menten proposed that enzyme catalysis proceeds through the formation of an enzyme-substrate (ES) complex. The simplest kinetic scheme is:
\[E + S \underset{k_{-1}}{\overset{k_1}{\rightleftharpoons}} ES \overset{k_2}{\rightarrow} E + P\]
Here, \(k_1\) is the rate constant for substrate binding, \(k_{-1}\) is the rate constant for substrate dissociation from the ES complex, and \(k_2\) (also called \(k_{\text{cat}}\)) is the catalytic rate constant (the turnover number) for conversion of ES to E + P.
3.2 The Steady-State Assumption
Briggs and Haldane (1925) improved the original Michaelis-Menten treatment with the steady-state assumption: after a brief initial transient, the concentration of ES remains approximately constant because it is being formed and consumed at equal rates:
\[\frac{d[ES]}{dt} = k_1[E][S] - k_{-1}[ES] - k_2[ES] = 0\]
Mathematical Deep Dive: Deriving the Michaelis-Menten Equation
Starting from the steady-state condition and the enzyme conservation equation:
Step 1: Express \([E]\) in terms of total enzyme: \([E]_T = [E] + [ES]\), so \([E] = [E]_T - [ES]\)
Step 2: Substitute into the steady-state equation:
\[k_1([E]_T - [ES])[S] - k_{-1}[ES] - k_2[ES] = 0\]
Step 3: Expand and collect terms with \([ES]\):
\[k_1[E]_T[S] = [ES](k_1[S] + k_{-1} + k_2)\]
Step 4: Solve for \([ES]\):
\[[ES] = \frac{[E]_T[S]}{[S] + \frac{k_{-1} + k_2}{k_1}}\]
Step 5: Define the Michaelis constant: \(K_m = \frac{k_{-1} + k_2}{k_1}\)
Step 6: The reaction velocity is \(v = k_2[ES]\), and the maximum velocity is \(V_{\max} = k_2[E]_T\):
\[\boxed{v = \frac{V_{\max}[S]}{K_m + [S]}}\]
This is the Michaelis-Menten equation — the foundational equation of enzyme kinetics.
3.3 Meaning of the Kinetic Parameters
\(K_m\) (Michaelis constant): The substrate concentration at which the reaction rate is half of \(V_{\max}\). When \([S] = K_m\), then \(v = V_{\max}/2\). \(K_m\) is an approximate measure of the affinity of the enzyme for its substrate — a low \(K_m\) indicates high affinity (the enzyme reaches half-maximal velocity at low substrate concentrations). Typical \(K_m\) values range from\(10^{-1}\) to \(10^{-7}\) M.
\(V_{\max}\): The maximum reaction velocity, achieved when the enzyme is fully saturated with substrate (\([S] \gg K_m\)). It depends on the total enzyme concentration: \(V_{\max} = k_{\text{cat}}[E]_T\).
\(k_{\text{cat}}\) (turnover number): The number of substrate molecules converted to product per enzyme molecule per unit time when the enzyme is saturated. Values range from \(\sim\)1 s\(^{-1}\) (lysozyme) to\(4 \times 10^7\) s\(^{-1}\) (carbonic anhydrase).
\(k_{\text{cat}}/K_m\) (catalytic efficiency): The best measure of overall enzyme performance. It represents the apparent second-order rate constant for the reaction of free enzyme with free substrate. The upper limit is the rate of diffusion-controlled encounter, approximately \(10^8\) to \(10^9\) M\(^{-1}\)s\(^{-1}\). Enzymes that reach this limit are called catalytically perfect.
Key Concept: Catalytically Perfect Enzymes
A handful of enzymes have evolved to the point where every encounter with substrate leads to catalysis — they are limited only by diffusion. Examples include triose phosphate isomerase (\(k_{\text{cat}}/K_m = 2.4 \times 10^8\) M\(^{-1}\)s\(^{-1}\)), carbonic anhydrase, acetylcholinesterase, and superoxide dismutase. These enzymes can only be made faster by physically co-localizing with their substrates (e.g., in multi-enzyme complexes or through metabolic channeling).
3.4 Linearization Methods
Before nonlinear regression became routine, linear transformations of the Michaelis-Menten equation were essential for determining \(K_m\) and \(V_{\max}\) from experimental data.
Lineweaver-Burk (double reciprocal) plot: Taking the reciprocal of both sides of the Michaelis-Menten equation:
\[\frac{1}{v} = \frac{K_m}{V_{\max}} \cdot \frac{1}{[S]} + \frac{1}{V_{\max}}\]
A plot of \(1/v\) vs \(1/[S]\) gives a straight line with slope \(K_m/V_{\max}\), y-intercept \(1/V_{\max}\), and x-intercept \(-1/K_m\). While widely used, this plot over-weights data at low \([S]\) (high \(1/[S]\)) where experimental error is largest.
Eadie-Hofstee plot: Rearranging to \(v\) as a function of \(v/[S]\):
\[v = V_{\max} - K_m \cdot \frac{v}{[S]}\]
Plotting \(v\) vs \(v/[S]\) gives slope \(-K_m\) and y-intercept \(V_{\max}\). This plot distributes errors more evenly and is preferred for visual detection of deviations from Michaelis-Menten behavior.
Hanes-Woolf plot: Rearranging to give \([S]/v\) as a function of \([S]\):
\[\frac{[S]}{v} = \frac{1}{V_{\max}}[S] + \frac{K_m}{V_{\max}}\]
Plotting \([S]/v\) vs \([S]\) gives slope \(1/V_{\max}\) and y-intercept\(K_m/V_{\max}\). This is the most statistically robust of the three linear transformations.
For Graduate Students: Multi-Substrate Kinetics
Most metabolic enzymes have two or more substrates. The kinetic mechanisms for bi-substrate reactions include: Sequential (both substrates bind before any product is released), which can be ordered (substrates bind in a defined sequence) or random (either can bind first); and Ping-Pong (the first substrate binds and transfers a group to the enzyme, forming a modified enzyme intermediate, before the second substrate binds). These mechanisms can be distinguished by characteristic patterns in double-reciprocal plots: sequential mechanisms give intersecting lines, while Ping-Pong mechanisms give parallel lines.
Chapter 4: Enzyme Regulation
Metabolic pathways must be regulated to respond to changing cellular needs. Enzyme regulation occurs on multiple timescales: milliseconds (allosteric regulation), seconds to minutes (covalent modification), and hours (changes in enzyme synthesis and degradation). Here we examine the molecular mechanisms of each.
4.1 Allosteric Regulation
Allosteric enzymes have regulatory sites distinct from the active site. Binding of effectors at these sites induces conformational changes that alter the enzyme's catalytic activity. Unlike Michaelis-Menten enzymes, allosteric enzymes typically display sigmoidal (S-shaped) kinetics rather than hyperbolic kinetics.
The Concerted (MWC) Model
Proposed by Monod, Wyman, and Changeux (1965), this model assumes that the enzyme exists in two conformational states: a relaxed (R) state with high substrate affinity and a tense (T) state with low substrate affinity. All subunits must be in the same state (concerted transition). The equilibrium between R and T states is characterized by the allosteric constant \(L = [T_0]/[R_0]\). Activators shift the equilibrium toward R; inhibitors shift it toward T.
The Sequential (KNF) Model
Proposed by Koshland, Nemethy, and Filmer (1966), this model allows individual subunits to change conformation independently. Substrate binding to one subunit induces a conformational change that influences the affinity of neighboring subunits. This model accommodates both positive cooperativity (each binding event increases affinity) and negative cooperativity (each binding event decreases affinity).
4.2 The Hill Equation
The Hill equation provides an empirical description of cooperative binding and allosteric kinetics:
\[v = \frac{V_{\max}[S]^{n_H}}{K_{0.5}^{n_H} + [S]^{n_H}}\]
where \(K_{0.5}\) is the substrate concentration at half-maximal velocity (analogous to \(K_m\)but not identical) and \(n_H\) is the Hill coefficient:
- \(n_H = 1\): No cooperativity (hyperbolic, Michaelis-Menten behavior)
- \(n_H > 1\): Positive cooperativity (sigmoidal curve, ultrasensitive response)
- \(n_H < 1\): Negative cooperativity (flattened curve)
Mathematical Deep Dive: The Hill Plot
Taking the logarithm of the Hill equation in its fractional saturation form:
\[\frac{v}{V_{\max} - v} = \frac{[S]^{n_H}}{K_{0.5}^{n_H}}\]
\[\log\left(\frac{v}{V_{\max} - v}\right) = n_H \log[S] - n_H \log K_{0.5}\]
A plot of \(\log(v/(V_{\max}-v))\) vs \(\log[S]\) (a Hill plot) gives a straight line with slope \(n_H\) near the midpoint. The Hill coefficient represents the minimumnumber of interacting binding sites and is always less than or equal to the actual number of subunits. For hemoglobin with 4 subunits, \(n_H \approx 2.8\).
4.3 Reversible Inhibition
Enzyme inhibitors are critical for metabolic regulation and are the basis of many pharmaceuticals. There are three principal types of reversible inhibition:
Competitive Inhibition
The inhibitor competes with the substrate for binding to the active site. It increases the apparent\(K_m\) but does not affect \(V_{\max}\) (which can still be reached at sufficiently high \([S]\)):
\[v = \frac{V_{\max}[S]}{\alpha K_m + [S]} \quad \text{where } \alpha = 1 + \frac{[I]}{K_i}\]
Uncompetitive Inhibition
The inhibitor binds only to the ES complex, not to free enzyme. Both apparent \(K_m\) and apparent \(V_{\max}\) are decreased by the same factor:
\[v = \frac{V_{\max}[S]}{K_m + \alpha'[S]} \quad \text{where } \alpha' = 1 + \frac{[I]}{K_i'}\]
Mixed (Noncompetitive) Inhibition
The inhibitor binds to both free enzyme and the ES complex, but with different affinities. Both \(K_m\) and \(V_{\max}\) are affected:
\[v = \frac{V_{\max}[S]}{\alpha K_m + \alpha'[S]}\]
When \(\alpha = \alpha'\) (the inhibitor binds E and ES equally well), this reduces to pure noncompetitive inhibition, where \(K_m\) is unchanged but \(V_{\max}\) is reduced.
| Inhibition Type | Binds to | Effect on \(K_m^{\text{app}}\) | Effect on \(V_{\max}^{\text{app}}\) | L-B Plot Pattern |
|---|---|---|---|---|
| Competitive | E only | Increases (\(\alpha K_m\)) | Unchanged | Lines intersect at y-axis |
| Uncompetitive | ES only | Decreases (\(K_m/\alpha'\)) | Decreases (\(V_{\max}/\alpha'\)) | Parallel lines |
| Mixed | E and ES | Increases or decreases | Decreases | Lines intersect left of y-axis |
4.4 Covalent Modification
Many metabolic enzymes are regulated by the reversible covalent attachment of chemical groups. The most common form is phosphorylation — the addition of a phosphoryl group from ATP to serine, threonine, or tyrosine residues by protein kinases. Removal is catalyzed by protein phosphatases. The human genome encodes over 500 protein kinases (the "kinome"), underscoring the centrality of this mechanism.
Phosphorylation can either activate or inhibit an enzyme, depending on the specific enzyme. For example, phosphorylation activates glycogen phosphorylase (promoting glycogen breakdown) but inhibits glycogen synthase (blocking glycogen synthesis). This reciprocal regulation ensures that glycogen is not simultaneously synthesized and degraded — a futile cycle that would waste ATP.
Other covalent modifications include acetylation (addition of acetyl groups to lysine residues), ubiquitination (tagging proteins for proteasomal degradation), SUMOylation,ADP-ribosylation, and methylation.
4.5 Zymogens and Proteolytic Activation
Some enzymes are synthesized as inactive precursors called zymogens (proenzymes). Activation occurs by irreversible proteolytic cleavage of one or more peptide bonds, which exposes or forms the active site. This mechanism is used when enzymes must be activated only at specific times and locations:
- Digestive enzymes: Pepsinogen \(\rightarrow\) pepsin, trypsinogen \(\rightarrow\) trypsin, chymotrypsinogen \(\rightarrow\) chymotrypsin
- Blood clotting cascade: A series of zymogen activations amplifies the initial signal, culminating in fibrin clot formation
- Apoptosis: Procaspases \(\rightarrow\) caspases in programmed cell death
4.6 Feedback Inhibition
In feedback (end-product) inhibition, the final product of a metabolic pathway inhibits the enzyme catalyzing the first committed step. This prevents wasteful accumulation of intermediates and ensures that pathway flux matches cellular demand. The inhibited enzyme is almost always allosteric, allowing the end product to bind at a regulatory site without competing with the substrate.
Clinical Relevance: Enzyme Inhibitors as Drugs
Many of the most successful drugs in medicine are enzyme inhibitors. Statins (e.g., atorvastatin) are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis. ACE inhibitors (e.g., lisinopril) block angiotensin-converting enzyme to lower blood pressure. Methotrexate inhibits dihydrofolate reductase in cancer chemotherapy. Aspirin irreversibly inhibits cyclooxygenase (COX) by acetylating a serine residue — a rare example of an irreversible covalent inhibitor used therapeutically. Understanding inhibition kinetics is essential for rational drug design.
Chapter 5: Coenzymes & Cofactors
Many enzymes require non-protein helpers to function. Cofactors is the general term for these helpers. They include metal ions (inorganic cofactors) and organic molecules called coenzymes. When a coenzyme is tightly or covalently bound to its enzyme, it is called a prosthetic group. Many coenzymes are derived from water-soluble vitamins, explaining why vitamin deficiencies impair metabolic function.
5.1 NAD\(^+\)/NADH — The Universal Electron Carrier
Nicotinamide adenine dinucleotide (NAD\(^+\)) is the most important oxidizing coenzyme in catabolism. It accepts two electrons and one proton (a hydride ion, H\(^-\)) from a substrate, becoming reduced to NADH:
\[\text{NAD}^+ + 2\text{H} \rightarrow \text{NADH} + \text{H}^+\]
The nicotinamide ring is the reactive portion. The reduction is stereospecific — dehydrogenases transfer the hydride to either the A-face (pro-R) or B-face (pro-S) of the nicotinamide ring, and each enzyme is specific for one face. NAD\(^+\)/NADH has a standard reduction potential of \(E^{\circ\prime} = -0.320\) V, indicating it is a moderately strong reducing agent in its reduced form.
NADPH (the phosphorylated form) serves a distinct role: it provides reducing equivalents for anabolic reactions (biosynthesis) rather than catabolic ones. The cell maintains separate NAD\(^+\)/NADH and NADP\(^+\)/NADPH pools with very different ratios:\([\text{NAD}^+]/[\text{NADH}] \approx 700\) (favoring oxidation) while\([\text{NADPH}]/[\text{NADP}^+] \approx 70\) (favoring reduction).
5.2 FAD/FADH\(_2\) — Flavin Chemistry
Flavin adenine dinucleotide (FAD) is derived from riboflavin (vitamin B\(_2\)). Unlike NAD\(^+\), FAD is usually a prosthetic group, tightly bound to its enzyme (called a flavoprotein). The isoalloxazine ring system of FAD can accept one or two electrons, allowing it to participate in both one-electron and two-electron transfers:
\[\text{FAD} \overset{e^-, H^+}{\longrightarrow} \text{FADH}^\bullet \overset{e^-, H^+}{\longrightarrow} \text{FADH}_2\]
The standard reduction potential of FAD/FADH\(_2\) is not a fixed value — it varies depending on the protein environment, ranging from about \(-0.40\) V to \(+0.06\) V. This tunability makes flavoproteins versatile redox catalysts. Key flavoenzymes include succinate dehydrogenase (Complex II), acyl-CoA dehydrogenase (fatty acid oxidation), and dihydrolipoyl dehydrogenase (in the pyruvate dehydrogenase complex).
5.3 Coenzyme A — Thioester Chemistry
Coenzyme A (CoA or CoA-SH) is derived from pantothenic acid (vitamin B\(_5\)), cysteine, and ATP. Its terminal sulfhydryl group forms thioester bonds with acyl groups. Thioesters are "high-energy" bonds — their hydrolysis is strongly exergonic (\(\Delta G^{\circ\prime} \approx -31.5\) kJ/mol for acetyl-CoA), comparable to ATP hydrolysis. This high free energy of hydrolysis makes the acyl group "activated" and thermodynamically primed for transfer to acceptor molecules.
Acetyl-CoA is the most important acyl-CoA derivative. It sits at a central metabolic crossroads: it is produced by the oxidation of glucose (via pyruvate dehydrogenase), fatty acids (via beta-oxidation), and amino acids, and it feeds into the citric acid cycle, fatty acid synthesis, ketone body formation, and cholesterol synthesis.
5.4 Other Essential Coenzymes
Thiamine pyrophosphate (TPP) — derived from thiamine (vitamin B\(_1\)), TPP catalyzes the oxidative decarboxylation of alpha-keto acids. The thiazolium ring stabilizes carbanion intermediates. Key enzymes: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase. Thiamine deficiency causes beriberi (wet and dry forms) and Wernicke-Korsakoff syndrome in alcoholics.
Pyridoxal phosphate (PLP) — derived from pyridoxine (vitamin B\(_6\)), PLP is the coenzyme for nearly all amino acid transformations: transamination, decarboxylation, racemization, elimination, and replacement reactions. It forms a Schiff base (aldimine) with the \(\alpha\)-amino group of the amino acid substrate. Over 140 distinct PLP-dependent enzymes are known.
Biotin — a CO\(_2\) carrier, covalently attached to carboxylase enzymes via a lysine residue. Key enzymes: pyruvate carboxylase (gluconeogenesis), acetyl-CoA carboxylase (fatty acid synthesis), propionyl-CoA carboxylase (odd-chain fatty acid metabolism). The carboxylation occurs in two steps: (1) ATP-dependent carboxylation of biotin, (2) transfer of CO\(_2\) from carboxybiotin to the substrate.
Tetrahydrofolate (THF) — derived from folic acid (vitamin B\(_9\)), THF carries one-carbon units at various oxidation states (methyl, methylene, methenyl, formyl, formimino). Essential for nucleotide biosynthesis (thymidylate and purine synthesis) and amino acid metabolism. Folate deficiency causes megaloblastic anemia due to impaired DNA synthesis.
5.5 Metal Ion Cofactors
Metal ions serve as cofactors for approximately one-third of all enzymes. Common roles include:
- Mg\(^{2+}\): Required by all kinases (stabilizes ATP/ADP), and by many phosphatases. Also essential for DNA/RNA polymerases.
- Zn\(^{2+}\): Catalytic role in carbonic anhydrase, carboxypeptidase A, alcohol dehydrogenase. Structural role in zinc finger proteins.
- Fe\(^{2+}\)/Fe\(^{3+}\): Found in heme proteins (hemoglobin, myoglobin, cytochromes) and iron-sulfur clusters (in the electron transport chain). The ability to cycle between oxidation states makes iron ideal for electron transfer.
- Cu\(^{+}\)/Cu\(^{2+}\): Found in cytochrome c oxidase (Complex IV), superoxide dismutase. Another redox-active metal.
- Mn\(^{2+}\): Found in the oxygen-evolving complex of photosystem II, arginase, and superoxide dismutase (MnSOD).
5.6 Reduction Potentials and the Nernst Equation
The standard reduction potential \(E^{\circ\prime}\) measures the tendency of a redox pair to accept electrons. A more positive \(E^{\circ\prime}\) indicates a stronger oxidizing agent (greater tendency to accept electrons). The relationship between reduction potential and free energy is:
\[\Delta G^{\circ\prime} = -nF\Delta E^{\circ\prime}\]
where \(n\) = number of electrons transferred, \(F = 96{,}485\) C/mol (Faraday constant)
| Redox Pair | \(E^{\circ\prime}\) (V) | \(n\) |
|---|---|---|
| 2H\(^+\)/H\(_2\) | -0.414 | 2 |
| NAD\(^+\)/NADH | -0.320 | 2 |
| FMN/FMNH\(_2\) (Complex I) | -0.300 | 2 |
| FAD/FADH\(_2\) (free) | -0.219 | 2 |
| Fumarate/Succinate | +0.031 | 2 |
| Ubiquinone (CoQ/CoQH\(_2\)) | +0.045 | 2 |
| Cytochrome c (Fe\(^{3+}\)/Fe\(^{2+}\)) | +0.254 | 1 |
| O\(_2\)/H\(_2\)O | +0.816 | 2 |
Mathematical Deep Dive: The Nernst Equation
The actual reduction potential under non-standard conditions is given by the Nernst equation:
\[E = E^{\circ\prime} - \frac{RT}{nF} \ln Q\]
At 25 \(^\circ\)C, this simplifies to:
\[E = E^{\circ\prime} - \frac{0.02569}{n} \ln \frac{[\text{reduced}]}{[\text{oxidized}]}\]
Example: The free energy available from the transfer of 2 electrons from NADH to O\(_2\) is:
\[\Delta E^{\circ\prime} = E^{\circ\prime}_{\text{acceptor}} - E^{\circ\prime}_{\text{donor}} = (+0.816) - (-0.320) = +1.136 \text{ V}\]
\[\Delta G^{\circ\prime} = -nF\Delta E^{\circ\prime} = -(2)(96{,}485)(1.136) = -219 \text{ kJ/mol}\]
This enormous free energy release (\(-219\) kJ/mol) is captured by the electron transport chain and used to drive the synthesis of approximately 2.5 ATP molecules per NADH.
Clinical Relevance: Vitamin Deficiencies and Coenzyme Function
Since many coenzymes derive from vitamins, deficiencies manifest as metabolic disorders. Niacin deficiency (pellagra) impairs NAD\(^+\)/NADH-dependent reactions, causing the "3 Ds": dermatitis, diarrhea, dementia. Thiamine deficiency impairs pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, leading to lactic acidosis and neurological damage (Wernicke encephalopathy). Riboflavin deficiency impairs flavoprotein function, causing angular stomatitis and normocytic anemia. Recognition of these clinical presentations requires understanding which metabolic pathways are affected.
Chapter 6: Metabolic Pathway Logic
With the thermodynamic, kinetic, and cofactor foundations established, we can now examine the organizational principles that govern metabolic pathways. Despite the apparent complexity of the metabolic map — with hundreds of enzymes and thousands of metabolites — a relatively small number of recurring patterns and design principles underlie all metabolic transformations.
6.1 Common Reaction Types in Metabolism
Most metabolic reactions fall into a handful of chemical categories. Recognizing these reaction types makes it much easier to learn and understand new pathways:
- Oxidation-Reduction: Transfer of electrons between molecules. Catalyzed by oxidoreductases (dehydrogenases, oxidases, reductases). These reactions typically involve NAD\(^+\), FAD, or direct O\(_2\) as electron acceptors/donors.
- Group Transfer: Transfer of a functional group (phosphoryl, acyl, amino, glycosyl) from a donor to an acceptor. Catalyzed by transferases. Examples: kinases (phosphoryl transfer from ATP), transaminases (amino group transfer via PLP).
- Hydrolysis: Cleavage of bonds by the addition of water. Catalyzed by hydrolases. Examples: proteases, lipases, phosphatases, ATPases.
- Ligation (bond formation): Joining two molecules, typically coupled to ATP hydrolysis. Catalyzed by ligases (synthetases). Examples: DNA ligase, glutamine synthetase, acetyl-CoA carboxylase.
- Isomerization: Intramolecular rearrangement. Catalyzed by isomerases and mutases. Examples: phosphoglucose isomerase (aldose-ketose conversion), methylmalonyl-CoA mutase (carbon skeleton rearrangement).
- Elimination/Addition: Removal or addition of groups (often H\(_2\)O or NH\(_3\)) across a double bond. Catalyzed by lyases. Examples: fumarase (addition of H\(_2\)O to fumarate), aconitase (dehydration/rehydration).
6.2 Committed Steps and Rate-Limiting Enzymes
The committed step is the first irreversible reaction unique to a particular pathway — the point of no return. The enzyme catalyzing this step is typically the most tightly regulated enzyme in the pathway and often (though not always) the rate-limiting step. Regulation at the committed step prevents wasteful accumulation of pathway intermediates when the end product is not needed.
Examples of committed steps and their regulatory enzymes:
| Pathway | Committed Step Enzyme | Key Regulators |
|---|---|---|
| Glycolysis | Phosphofructokinase-1 (PFK-1) | ATP (-), AMP (+), citrate (-), fructose-2,6-bisphosphate (+) |
| Gluconeogenesis | Fructose-1,6-bisphosphatase | AMP (-), fructose-2,6-bisphosphate (-), citrate (+) |
| Fatty acid synthesis | Acetyl-CoA carboxylase (ACC) | Citrate (+), palmitoyl-CoA (-), phosphorylation by AMPK (-) |
| Cholesterol synthesis | HMG-CoA reductase | Cholesterol (-), statins (-), SREBP (+) |
| Citric acid cycle | Isocitrate dehydrogenase | ADP (+), Ca\(^{2+}\) (+), ATP (-), NADH (-) |
6.3 Near-Equilibrium vs Far-from-Equilibrium Reactions
In any metabolic pathway, most reactions operate near equilibrium (\(\Delta G \approx 0\)), while a few operate far from equilibrium (\(\Delta G \ll 0\)). This distinction is functionally crucial:
- Near-equilibrium reactions are catalyzed by enzymes present in high activity. They respond passively to changes in substrate/product concentration and are freely reversible in vivo. They do not serve as regulatory points.
- Far-from-equilibrium reactions are catalyzed by regulated enzymes present in lower activity. They are essentially irreversible under cellular conditions and serve as the regulatory "valves" that control pathway flux. These are the targets of allosteric regulation, covalent modification, and hormonal control.
Key Concept: Metabolic Flux
Metabolic flux (\(J\)) is the rate at which material flows through a pathway. At steady state, the flux through every step in a linear pathway is the same. Flux is controlled primarily at the far-from-equilibrium steps. Metabolic control analysis (MCA) provides a quantitative framework: the flux control coefficient \(C^J_i\) for enzyme \(i\) measures the fractional change in pathway flux resulting from a fractional change in that enzyme's activity. The summation theorem states that all flux control coefficients in a pathway sum to 1: \(\sum_i C^J_i = 1\). This means control is shared among enzymes, though it is often concentrated at one or a few steps.
6.4 Catabolism vs Anabolism
Metabolism is divided into two broad categories:
Catabolism (degradative pathways): Complex molecules are broken down to simpler ones, releasing free energy that is captured as ATP and reduced coenzymes (NADH, FADH\(_2\)). Catabolic pathways are convergent — many different fuels (glucose, fatty acids, amino acids) are degraded to a few common intermediates (acetyl-CoA, pyruvate, TCA cycle intermediates).
Anabolism (biosynthetic pathways): Simple precursors are assembled into complex macromolecules, consuming ATP and NADPH. Anabolic pathways are divergent — a few simple precursors give rise to an enormous variety of products (proteins, nucleic acids, lipids, polysaccharides).
Opposing catabolic and anabolic pathways (e.g., glycolysis/gluconeogenesis, fatty acid oxidation/synthesis) are never simply the reverse of each other. They differ in at least one enzymatic step and are regulated reciprocally — when one is active, the other is suppressed. This ensures that futile cycling (simultaneous synthesis and degradation) is minimized.
6.5 Amphibolic Pathways
Some pathways serve both catabolic and anabolic functions and are termed amphibolic. The citric acid cycle is the most prominent example: it oxidizes acetyl-CoA to CO\(_2\) (catabolism) but also provides carbon skeletons for biosynthesis — oxaloacetate for gluconeogenesis, alpha-ketoglutarate for amino acid synthesis, succinyl-CoA for porphyrin synthesis, and citrate for fatty acid synthesis.
When TCA cycle intermediates are withdrawn for biosynthesis, they must be replenished by anaplerotic reactions. The most important is the carboxylation of pyruvate to oxaloacetate, catalyzed by pyruvate carboxylase (a biotin-dependent enzyme activated by acetyl-CoA):
\[\text{Pyruvate} + \text{CO}_2 + \text{ATP} \rightarrow \text{Oxaloacetate} + \text{ADP} + \text{P}_i\]
6.6 Overview of Major Metabolic Pathways
The following is a preview of the major pathways we will study in detail in subsequent parts of this course. Each pathway will be examined at the level of individual enzymatic reactions, with complete attention to stereochemistry, mechanism, energetics, and regulation.
Carbohydrate Metabolism (Part II)
- Glycolysis (glucose \(\rightarrow\) 2 pyruvate)
- Gluconeogenesis (pyruvate \(\rightarrow\) glucose)
- Pentose phosphate pathway
- Glycogen synthesis and degradation
- Galactose and fructose metabolism
TCA Cycle & OxPhos (Part III)
- Pyruvate dehydrogenase complex
- Citric acid cycle (8 reactions)
- Electron transport chain (Complexes I-IV)
- ATP synthase and chemiosmotic coupling
- Regulation and integration
Lipid Metabolism (Part IV)
- Fatty acid beta-oxidation
- Fatty acid synthesis
- Ketone body metabolism
- Cholesterol and steroid synthesis
- Eicosanoid metabolism
Amino Acids & Nucleotides (Part V)
- Amino acid catabolism and the urea cycle
- One-carbon metabolism
- Purine and pyrimidine biosynthesis
- Nucleotide degradation
- Porphyrin and heme metabolism
For Graduate Students: Systems Approaches to Metabolism
Modern metabolic research increasingly uses systems-level approaches. Flux balance analysis (FBA) uses genome-scale metabolic models (GEMs) containing thousands of reactions to predict metabolic flux distributions by linear programming under constraints of mass balance and reaction capacity. Metabolomics uses mass spectrometry and NMR to measure the concentrations of hundreds of metabolites simultaneously, providing snapshots of metabolic state. \(^{13}\)C metabolic flux analysis uses isotope tracing to quantify actual in vivo fluxes through metabolic networks. These approaches reveal emergent properties of metabolism — robustness, modularity, bow-tie architecture — that are not apparent from studying individual pathways in isolation.
Clinical Relevance: Inborn Errors of Metabolism
Archibald Garrod (1908) first recognized that genetic mutations could block specific metabolic steps, causing "inborn errors of metabolism." Today, over 500 such disorders are known. They follow a common pattern: the substrate of the defective enzyme accumulates (often to toxic levels), the product is deficient, and alternative metabolic routes may produce abnormal metabolites. Examples include phenylketonuria (PKU, deficiency of phenylalanine hydroxylase), galactosemia (galactose-1-phosphate uridylyltransferase deficiency), and maple syrup urine disease (branched-chain alpha-keto acid dehydrogenase deficiency). Newborn screening programs now test for many of these conditions, enabling early dietary intervention.